News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,515 Results
Type
Article (494)
Company Profile (15)
Press Release (24006)
Section
Business (10932)
Career Advice (15)
Deals (1872)
Drug Development (2289)
Employer Resources (1)
FDA (509)
Job Trends (720)
News (14869)
Policy (964)
Tag
Academia (69)
Accelerated approval (1)
Allergies (10)
Alliances (967)
ALS (2)
Alzheimer's disease (32)
Antibody-drug conjugate (ADC) (4)
Approvals (545)
Artificial intelligence (2)
Autoimmune disease (3)
Bankruptcy (4)
Best Places to Work (714)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (9)
Bladder cancer (10)
Breast cancer (14)
Cancer (127)
Cardiovascular disease (13)
Career advice (12)
Career pathing (2)
CAR-T (8)
Cell therapy (34)
Cervical cancer (1)
Clinical research (2100)
Collaboration (24)
Compensation (16)
COVID-19 (107)
CRISPR (3)
C-suite (4)
Cystic fibrosis (3)
Data (258)
Depression (2)
Diabetes (17)
Diagnostics (225)
Digital health (3)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (3)
Earnings (9765)
Editorial (2)
Employer resources (2)
Events (3396)
Executive appointments (8)
FDA (692)
Fibrodysplasia Ossificans Progressiva (1)
Funding (25)
Gene editing (3)
Gene therapy (11)
GLP-1 (24)
Government (175)
Guidances (96)
Healthcare (938)
HIV (10)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (3)
Immuno-oncology (1)
Indications (4)
Infectious disease (118)
Inflammatory bowel disease (7)
Influenza (4)
Intellectual property (1)
Interviews (1)
IPO (1402)
Job creations (45)
Job search strategy (6)
JPM (2)
Kidney cancer (1)
Labor market (3)
Layoffs (8)
Legal (136)
Liver cancer (4)
Longevity (1)
Lung cancer (19)
Lymphoma (15)
Manufacturing (13)
MASH (5)
Medical device (669)
Medtech (672)
Mergers & acquisitions (497)
Metabolic disorders (40)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (2)
Neuroscience (58)
NextGen: Class of 2026 (182)
Non-profit (112)
Obesity (18)
Opinion (1)
Ovarian cancer (3)
Pain (5)
Pancreatic cancer (1)
Parkinson's disease (2)
Partnered (2)
Patents (1)
Patient recruitment (7)
Peanut (5)
People (984)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase 1 (487)
Phase 2 (783)
Phase 3 (972)
Pipeline (457)
Policy (2)
Postmarket research (101)
Preclinical (157)
Press Release (3)
Prostate cancer (4)
Radiopharmaceuticals (10)
Rare diseases (30)
Real estate (86)
Recruiting (2)
Regulatory (775)
Reports (4)
Research institute (49)
Resumes & cover letters (7)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (5)
Series A (1)
Series B (3)
Sickle cell disease (6)
Special edition (2)
Spinal muscular atrophy (4)
Sponsored (2)
Startups (44)
State (1)
Supply chain (1)
Vaccines (27)
Venture capital (3)
Weight loss (8)
Women's health (11)
Date
Last 7 days (23)
Last 30 days (57)
Last 365 days (1283)
2026 (76)
2025 (1316)
2024 (1608)
2023 (1820)
2022 (1992)
2021 (2005)
2020 (5526)
2019 (1415)
2018 (1108)
2017 (827)
2016 (559)
2015 (806)
2014 (617)
2013 (394)
2012 (447)
2011 (567)
2010 (476)
Location
Africa (6)
Alabama (2)
Arizona (7)
Asia (1623)
Australia (103)
California (411)
Canada (108)
China (21)
Colorado (23)
Connecticut (20)
Delaware (30)
Europe (3095)
Florida (60)
Georgia (18)
Idaho (1)
Illinois (35)
India (2)
Indiana (23)
Iowa (1)
Japan (14)
Kansas (1)
Kentucky (1)
Louisiana (4)
Maine (7)
Maryland (63)
Massachusetts (352)
Michigan (18)
Minnesota (22)
Missouri (11)
Montana (2)
Nevada (3)
New Hampshire (2)
New Jersey (189)
New York (126)
North Carolina (54)
Northern California (215)
Ohio (7)
Oregon (1)
Pennsylvania (192)
Rhode Island (1)
South America (26)
Southern California (163)
Tennessee (5)
Texas (55)
United States (1745)
Utah (14)
Virginia (7)
Washington State (40)
Wisconsin (3)
24,515 Results for "215".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ImmunityBio Launches Phase 2 Chemotherapy-Free CAR-NK Cell Therapy Trial with ANKTIVA® (ResQ215B) in Indolent Lymphomas
February 2, 2026
·
9 min read
Press Releases
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
January 9, 2026
·
3 min read
Press Releases
NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
November 13, 2025
·
4 min read
Press Releases
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
January 9, 2026
·
1 min read
Press Releases
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors
November 21, 2025
·
3 min read
Press Releases
NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
November 18, 2025
·
5 min read
Press Releases
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
October 27, 2025
·
5 min read
Press Releases
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
November 10, 2025
·
8 min read
Press Releases
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
April 15, 2025
·
3 min read
Press Releases
HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration
June 10, 2025
·
4 min read
1 of 2,452
Next
